Bellevue Group’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $260M | Buy |
|
|||||
|
2025
Q2 | $168M | Buy |
|
|||||
|
2025
Q1 | $155M | Sell |
|
|||||
|
2024
Q4 | $192M | Sell |
|
|||||
|
2024
Q3 | $221M | Sell |
|
|||||
|
2024
Q2 | $195M | Sell |
|
|||||
|
2024
Q1 | $164M | Sell |
|
|||||
|
2023
Q4 | $146M | Buy |
|
|||||
|
2023
Q3 | $131M | Sell |
|
|||||
|
2023
Q2 | $127M | Sell |
|
|||||
|
2023
Q1 | $103M | Sell |
|
|||||
|
2022
Q4 | $116M | Buy |
|
|||||
|
2022
Q3 | $92.3M | Buy |
|
|||||
|
2022
Q2 | $65.9M | Buy |
|
|||||
|
2022
Q1 | $84.5M | Sell |
|
|||||
|
2021
Q4 | $87.3M | Buy |
|
|||||
|
2021
Q3 | $95.2M | Buy |
|
|||||
|
2021
Q2 | $58.9M | Buy |
|
|||||
|
2021
Q1 | $48.9M | Buy |
|
|||||
|
2020
Q4 | $1.58M | Buy |
|